Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round ...

Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

A trial of Biogen’s spinal muscular atrophy (SMA) therapy Spinraza (nusinersen) suggests that a higher dose provides benefits ...

After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...